We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-2.5%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$333B
AUM Growth
-$5.65B
Cap. Flow
+$10.7B
Cap. Flow %
3.22%
Top 10 Hldgs %
17.75%
Holding
3,695
New
106
Increased
2,783
Reduced
461
Closed
115

Top Buys

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$727M
2
HD icon
Home Depot
HD
+$472M
3
PFE icon
Pfizer
PFE
+$362M
4
TXN icon
Texas Instruments
TXN
+$314M
5
LYB icon
LyondellBasell Industries
LYB
+$299M

Sector Composition

Rank Sector Weight
1 Technology 21.07%
2 Financials 12.97%
3 Healthcare 12.01%
4 Consumer Discretionary 10.22%
5 Industrials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KBAL
2701
DELISTED
Kimball International
KBAL
$1.72M ﹤0.01%
202,952
+108,556
+115% +$1.03M
EGIO
2702
DELISTED
Edgio, Inc. Common Stock
EGIO
$1.71M ﹤0.01%
8,205
-57
-0.7% -$9.5K
FULC icon
2703
Fulcrum Therapeutics
FULC
$290M
$1.71M ﹤0.01%
72,209
+1,724
+2% +$24.4K
OPRX icon
2704
OptimizeRx
OPRX
$129M
$1.7M ﹤0.01%
45,103
+1,033
+2% +$45.7K
LYLT
2705
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$1.7M ﹤0.01%
102,867
-39,677
-28% -$984K
VLDR
2706
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$1.7M ﹤0.01%
664,376
+20,575
+3% +$70.4K
HNST icon
2707
The Honest Company
HNST
$428M
$1.69M ﹤0.01%
323,801
+10,697
+3% +$64.4K
KZR
2708
DELISTED
Kezar Life Sciences
KZR
$1.68M ﹤0.01%
10,112
+1,172
+13% +$168K
BASE
2709
DELISTED
Couchbase
BASE
$1.68M ﹤0.01%
96,137
+32,165
+50% +$652K
MITK icon
2710
Mitek Systems
MITK
$800M
$1.66M ﹤0.01%
113,399
+1,729
+2% +$26.5K
NDLS icon
2711
Noodles & Co
NDLS
$106M
$1.66M ﹤0.01%
34,761
+695
+2% +$42.7K
HBIO icon
2712
Harvard Bioscience
HBIO
$28.5M
$1.65M ﹤0.01%
26,619
+5,632
+27% +$333K
MUX icon
2713
McEwen Inc
MUX
$1.12B
$1.65M ﹤0.01%
195,748
+4,761
+2% +$41.1K
IMVT icon
2714
Immunovant
IMVT
$8.08B
$1.64M ﹤0.01%
298,115
+7,183
+2% +$44.7K
VZIO
2715
DELISTED
VIZIO Holding Corp.
VZIO
$1.64M ﹤0.01%
184,140
+4,468
+2% +$59.5K
LE icon
2716
Lands' End
LE
$395M
$1.63M ﹤0.01%
96,543
+2,831
+3% +$50.6K
BHR
2717
Braemar Hotels & Resorts
BHR
$144M
$1.62M ﹤0.01%
262,279
-292,458
-53% -$1.67M
LOCO icon
2718
El Pollo Loco
LOCO
$503M
$1.61M ﹤0.01%
138,505
+2,288
+2% +$29.5K
RUBY
2719
DELISTED
Rubius Therapeutics, Inc
RUBY
$1.61M ﹤0.01%
291,877
-13,389
-4% -$85K
ABSI icon
2720
Absci
ABSI
$1.44B
$1.59M ﹤0.01%
189,020
+94,600
+100% +$743K
CRAI icon
2721
CRA International
CRAI
$1.17B
$1.59M ﹤0.01%
18,851
+331
+2% +$29K
SNPO
2722
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
$1.58M ﹤0.01%
107,379
+12,230
+13% +$225K
IIIV icon
2723
i3 Verticals
IIIV
$427M
$1.58M ﹤0.01%
56,672
+1,679
+3% +$41.4K
CLAR icon
2724
Clarus
CLAR
$129M
$1.57M ﹤0.01%
68,772
+1,547
+2% +$35.8K
DFH icon
2725
Dream Finders Homes
DFH
$1.3B
$1.57M ﹤0.01%
91,690
+2,170
+2% +$41.7K

Similar funds

Charles Schwab's Q1 2022 Portfolio in Review

As of Q1 2022, Charles Schwab held 3,695 positions worth $333B, down 1.7% from $339B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Charles Schwab deployed $10.7B of net new capital in Q1 2022, opening 106 new positions and adding to 2,783 existing holdings. Its largest new stake was Constellation Energy: 1,449,939 shares worth $81.6M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Emerson Electric, an estimated $567M trimmed.

  • Charles Schwab's largest Q1 2022 buy was Constellation Energy: 1,449,939 shares worth $81.6M.
  • Charles Schwab added most to EOG Resources in Q1 2022, an estimated $727M increase.
  • Charles Schwab's biggest Q1 2022 reduction was Emerson Electric, cutting an estimated $567M.
  • Charles Schwab fully exited Xilinx Inc in Q1 2022, selling an estimated $245M.
  • Charles Schwab's ten largest holdings make up 18% of its $333B portfolio in Q1 2022.
  • Charles Schwab opened 106 new positions and closed 115 in Q1 2022.
  • Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $333B.

Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.